Company

Exact Sciences Corporation

Headquarters: Madison, WI, United States

Founded: 1995

Employees: 6,420

CEO: Mr. Kevin T. Conroy

NASDAQ: EXAS +1.11%

Market Cap

$12.88 Billion

USD as of Jan. 1, 2024

Market Cap History

Exact Sciences Corporation market capitalization over time

Evolution of Exact Sciences Corporation market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Exact Sciences Corporation

Detailed Description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Exact Sciences Corporation has the following listings and related stock indices.


Stock: NASDAQ: EXAS wb_incandescent

Stock: FSX: EXK wb_incandescent

Product & Services

Cologuard

Key People

Founder(s): Stanley Lapidus, Anthony P. Shuber

Kevin Conroy (Chairman, President & CEO) Graham Lidgard (Chief Science Officer)

Financials

Revenue: $1.49 Billion (2020)

Details

Headquarters:

441 Charmany Drive

Madison, WI 53719

United States

Phone: 608 284 5700